Microarray analysis revealed significantly elevated TROP2 transcription levels in CRLM and matched primary lesions compared to CRC cases without metastasis, as confirmed by a minimum follow‐up of three years (Figure 1B). This evidence concerns the gene TACSTD2 and colorectal carcinoma.